SEC Filing Summary for CorMedix Inc. - Officer Transaction

2026-09-01SEC Filing 4 (0001213900-26-096385)

This filing details a transaction by Elizabeth Hurlburt, Chief Operating Officer of CorMedix Inc. On August 29, 2026, Ms. Hurlburt disposed of 8,076 shares of Common Stock at a price of $8.30 per share. Following this transaction, she owns 270,463 shares of CorMedix Inc. stock directly. The transaction code is "F", indicating a sale or other disposition of securities.